APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,619 | +30.2% | 138,513 | -26.1% | 0.02% | +38.5% |
| Q4 2022 | $9,691 | -100.0% | 187,413 | -45.7% | 0.01% | -60.6% |
| Q3 2022 | $23,571,000 | +1745.8% | 345,113 | +1607.6% | 0.03% | +1550.0% |
| Q2 2021 | $1,277,000 | -92.0% | 20,211 | -94.6% | 0.00% | -90.0% |
| Q1 2021 | $16,027,000 | +29.5% | 373,513 | +72.7% | 0.02% | +53.8% |
| Q4 2020 | $12,373,000 | +1972.5% | 216,313 | +1008.6% | 0.01% | – |
| Q4 2019 | $597,000 | +16.8% | 19,513 | -25.5% | 0.00% | – |
| Q1 2019 | $511,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |